Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to asses changes in glycosylated hemoglobin, fasting blood
lipids and genetic polymorphism's in peroxisomal proliferator activated receptors--gamma
receptor after 6 months of pioglitazone, once daily (QD), treatment.